CareDx, Inc (CDNA) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 10 Buy, 3 Hold.
The consensus price target is $23.33 (low: $18.00, high: $26.00), representing an upside of 32.3% from the current price $17.63.
Analysts estimate Earnings Per Share (EPS) of $-0.90 and revenue of $0.33B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.00 vs est $-0.90 (beat +211.7%). 2025: actual $-0.40 vs est $-0.30 (missed -34%). Analyst accuracy: 0%.
CDNA Stock — 12-Month Price Forecast
$23.33
▲ +32.33% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for CareDx, Inc, the average price target is $23.33, with a high forecast of $26.00, and a low forecast of $18.00.
The average price target represents a +32.33% change from the last price of $17.63.
Highest Price Target
$26.00
Average Price Target
$23.33
Lowest Price Target
$18.00
CDNA Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to CareDx, Inc in the past 3 months
EPS Estimates — CDNA
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.00
vs Est –$0.90
▲ 189.5% off
2025
Actual –$0.40
vs Est –$0.30
▼ 25.4% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect losses to continue near-term.
Revenue Estimates — CDNA
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.334B
vs Est $0.331B
▲ 0.7% off
2025
Actual $0.380B
vs Est $0.375B
▲ 1.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
